AN2 Therapeutics ANTX SEC Filings

NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing AN2 Therapeutics, Inc. (ANTX) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-452664Nov 9, 2026 12:33 PM
28-KCurrent Report0001193125-26-452660Nov 9, 2026 12:31 PM
34Insider Transaction0001193125-26-452184Nov 6, 2026 11:20 PM
44Insider Transaction0001193125-26-420643Oct 13, 2026 1:13 AM
54Insider Transaction0001193125-26-420641Oct 13, 2026 1:12 AM
64Insider Transaction0001193125-26-420639Oct 13, 2026 1:12 AM
74Insider Transaction0001193125-26-393274Sep 16, 2026 5:35 PM
8S-8Prospectus0001880438-26-000002Sep 14, 2026 8:06 PM
94Insider Transaction0001193125-26-389545Sep 11, 2026 11:45 PM
104Insider Transaction0001193125-26-385511Sep 8, 2026 11:42 PM
114Insider Transaction0001193125-26-383697Sep 4, 2026 8:25 PM
124Insider Transaction0001193125-26-380595Sep 2, 2026 10:43 PM
133Insider Transaction0001193125-26-370943Aug 27, 2026 6:15 PM
144Insider Transaction0001193125-26-357225Aug 19, 2026 9:58 PM
15144Insider Transaction0001972481-26-000263Aug 17, 2026 8:24 PM
164Insider Transaction0001193125-26-351801Aug 14, 2026 6:12 PM
1710-QQuarterly & Annual Report0001193125-26-344569Aug 11, 2026 8:04 PM
188-KCurrent Report0001193125-26-344549Aug 11, 2026 8:01 PM
194Insider Transaction0001193125-26-301167Jul 10, 2026 11:41 PM
204Insider Transaction0001193125-26-301166Jul 10, 2026 11:41 PM
214Insider Transaction0001193125-26-301165Jul 10, 2026 11:40 PM
224Insider Transaction0001193125-26-301092Jul 10, 2026 10:15 PM
238-KCurrent Report0001193125-26-262264Jun 9, 2026 10:23 PM
248-KCurrent Report0001193125-26-257430Jun 4, 2026 8:15 PM
254Insider Transaction0001193125-26-253622Jun 2, 2026 8:31 PM
26SCHEDULE 13GBeneficial Ownership Report0002073679-26-000066May 15, 2026 1:58 AM
2710-QQuarterly & Annual Report0001193125-26-216755May 11, 2026 8:08 PM
288-KCurrent Report0001193125-26-216752May 11, 2026 8:06 PM
29ARSOthers0001193125-26-170328Apr 22, 2026 8:03 PM
30DEFA14AOthers0001193125-26-170321Apr 22, 2026 8:02 PM
31DEF 14AOthers0001193125-26-170314Apr 22, 2026 8:01 PM
32EFFECTOthers9999999995-26-001256Apr 20, 2026 4:15 AM
33424B3Prospectus0001193125-26-164101Apr 20, 2026 8:33 PM
34424B5Prospectus0001193125-26-164095Apr 20, 2026 8:32 PM
35CORRESPOthers0001193125-26-158794Apr 16, 2026 7:21 PM
36UPLOADOthers0000000000-26-003830Apr 15, 2026 7:00 PM
374Insider Transaction0001193125-26-151632Apr 10, 2026 12:58 AM
384Insider Transaction0001193125-26-151628Apr 10, 2026 12:53 AM
394Insider Transaction0001193125-26-151626Apr 10, 2026 12:51 AM
40S-3Prospectus0001193125-26-149869Apr 9, 2026 9:21 PM
418-KCurrent Report0001193125-26-149822Apr 9, 2026 9:03 PM
42DOthers0001880438-26-000001Mar 25, 2026 8:42 PM
434Insider Transaction0001193125-26-120236Mar 23, 2026 11:16 PM
444Insider Transaction0001193125-26-120235Mar 23, 2026 11:16 PM
454Insider Transaction0001193125-26-120230Mar 23, 2026 11:13 PM
464Insider Transaction0001193125-26-120226Mar 23, 2026 11:11 PM
474Insider Transaction0001193125-26-120223Mar 23, 2026 11:10 PM
484Insider Transaction0001193125-26-120221Mar 23, 2026 11:09 PM
494Insider Transaction0001193125-26-120216Mar 23, 2026 11:08 PM
504Insider Transaction0001193125-26-120214Mar 23, 2026 11:07 PM
...

AN2 Therapeutics, Inc. SEC Filings API

Pull AN2 Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ANTX&formtype=10-K,10-Q&api_key=YOUR_API_KEY